10x Genomics, Inc. (TXG) stock
TXGNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30111% above fair value
$56.30+1.31 (+2.38%)
Close on Nov 17, 2026Market cap $7.34BP/E –Yield –
10x Genomics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
10x Genomics's enterprise value was $7.37B on Nov 11, 2026, against $1.84B a year earlier. Over the last 5 years it ranged from $617.95M to $15.66B, with a median of $3.67B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $7.37B | +381.0% |
| 2025 | Dec 31, 2025 | $1.53B | +16.1% |
| 2024 | Dec 31, 2024 | $1.32B | -78.5% |
| 2023 | Dec 29, 2023 | $6.14B | +67.7% |
| 2022 | Dec 30, 2022 | $3.66B | -76.6% |
| 2021 | Dec 31, 2021 | $15.66B | +10.9% |
| 2020 | Dec 31, 2020 | $14.12B | +105.2% |
| 2019 | Dec 31, 2019 | $6.88B | – |
See a number that looks wrong?